Your browser doesn't support javascript.
Once-weekly  semaglutide  for obesity  or overweight: A systematic review and meta-analysis.
He, Ke; Guo, Qing; Zhang, Haijuan; Xi, Wang; Li, Jingxin; Jing, Zeng.
  • He K; Department of Pharmacy, The Fourth Hospital of Shijiazhuang/Shijiazhuang Obstetrics and Gynecology Hospital, Shijiazhuang, China.
  • Guo Q; Department of Obstetrics and Gynecology, The Fourth Hospital of Shijiazhuang/Shijiazhuang Obstetrics and Gynecology Hospital, Shijiazhuang, China.
  • Zhang H; Department of Obstetrics and Gynecology, The Fourth Hospital of Shijiazhuang/Shijiazhuang Obstetrics and Gynecology Hospital, Shijiazhuang, China.
  • Xi W; Department of Neurosurgery, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
  • Li J; Department of Chinese Pharmacy, Hebei Maternity Hospital, Shijiazhuang, China.
  • Jing Z; Department of Pharmacy, The Fourth Hospital of Shijiazhuang/Shijiazhuang Obstetrics and Gynecology Hospital, Shijiazhuang, China.
Diabetes Obes Metab ; 24(4): 722-726, 2022 04.
Article in English | MEDLINE | ID: covidwho-1583590
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Overweight Type of study: Reviews / Systematic review/Meta Analysis Topics: Long Covid Limits: Humans Language: English Journal: Diabetes Obes Metab Journal subject: Endocrinology / Metabolism Year: 2022 Document Type: Article Affiliation country: Dom.14612

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Overweight Type of study: Reviews / Systematic review/Meta Analysis Topics: Long Covid Limits: Humans Language: English Journal: Diabetes Obes Metab Journal subject: Endocrinology / Metabolism Year: 2022 Document Type: Article Affiliation country: Dom.14612